Scientists are exploring an unexpected ally in the fight against heart disease: avocados.
A recent study published in the Journal of Cellular and Molecular Medicine entitled, Avocado-derived extracellular vesicles loaded with ginkgetin and berberine prevent inflammation and macrophage foam cell formation, investigated whether tiny particles naturally found in avocados could deliver plant-based compounds directly into immune cells involved in atherosclerosis—the artery-clogging process behind many heart attacks and strokes.
Atherosclerosis begins when immune cells called macrophages absorb oxidized LDL (“bad cholesterol”). These overloaded cells become “foam cells,” which accumulate inside artery walls and trigger chronic inflammation. Over time, this buildup narrows arteries and increases cardiovascular risk.
The researchers in this study isolated extracellular vesicles—tiny membrane-bound particles—from avocados. These vesicles act like natural delivery systems that can transport molecules into cells for drug delivery. The traditional challenge has been that two of the compounds used in this study, Berberine and Ginkgetin, don’t easily survive digestion or efficiently enter cells.
The team loaded the vesicles with the two compounds, and the vesicles successfully carried these compounds into macrophages in laboratory experiments.
What the Study Found
The combined treatment produced several promising effects:
1. Reduced Inflammatory Signaling
2. Lower Expression of Harmful Genes
3. Less Foam Cell Formation
4. Blockage of Cholesterol Uptake
The study highlights a growing field of research focused on plant-derived compounds as natural drug delivery systems. Instead of relying solely on synthetic nanoparticles, researchers are investigating whether edible plants can provide safer, more biocompatible delivery vehicles for therapeutics.
This research is still early-stage and was conducted primarily in laboratory mouse cell models—not human patients. Still, the findings suggest a fascinating future where food-derived nanotechnology could help deliver targeted therapies for chronic inflammatory diseases.
The extracellular vesicles in the study were characterized for size, polydispersity and zeta potential using a Brookhaven Instruments NanoBrook Omni combined dynamic light scattering and zeta potential instrument. Brookhaven Instruments is proud to have played a small role in this research.
# # #
Brookhaven Instruments, with a legacy of pioneering in light scattering and zeta potential analysis, is committed to advancing its technology to provide reliable and innovative solutions that support modern scientific breakthroughs in nanotechnology, pharmaceuticals, and materials science. We have dedicated support resources to help you along the way. We are real people helping real people in real-time.TM Our instruments have always been built in the USA.
Contact us today to learn more about our light scattering solutions for particle size and zeta potential analysis.